佛山市62例应用重组人生长激素的矮小儿童随访调查  

Investigation of the application of rhGH in 62 children with short stature in Foshan

作　　者：李颖仪[1] 卢结文[1] 张红雨[1] 黎创幸[1] 吴维英[1] 吴杏梅[1] 

机构地区：[1]佛山市第一人民医院药剂科,广东佛山528000

出　　处：《中国现代医学杂志》2011年第34期4303-4306,共4页China Journal of Modern Medicine

摘　　要：目的随访佛山地区应用重组人生长激素治疗的矮小儿童62例,探讨其应用rhGH时的病因、应用时间、疗效、副作用情况。方法对已应用rhGH的62例不同原因矮小儿童,采用统一的调查表,通过患者信息登记表获取患者资料进行随访。随访内容包括:应用rhGH的病因、应用时间、疗效、副作用情况。结果使用生长激素的病因复杂;用药时间多在12个月以内,占全部患儿的48.7%;且在治疗的前6个月生长速度明显快于后6个月。结论 rhGH治疗副作用小,促进患儿的生长发育,提高患儿最终身高。[ Objective ] According to the follow-up of 62 children who have taken rhGH for short stature in Foshan, to discuss the cause of disease, the application time, the curative effect and side effect of rhGH. [Methods] With unified investigation table, the follow-up information of 62 children took rhGH for short stature ,which included the reason of using rhGH, lasting time, curative effect and side effect of administration, were collected. [Results] Children with short stature used rhGH for many reasons. Patients with 12 months administration accounted 48.7%, with a obviously quicker growth in first 6 months compared with that in latter 6 months. [ Conclusion ] rhGH has a great curative effect and a poor side effect for short stature.

关 键 词：生长激素 矮小 儿童 

分 类 号：R720.5[医药卫生—儿科]